Dexamethasone Tablet
NDC Package 68047-702-35

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Dexamethasone (dexamethasone 1.5 mg) tablets is dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. This formulation utilizes a tablet delivery system. Marketed by Larken Laboratories, Inc., this product is identified by NDC 68047-702 and is authorized under FDA application ANDA201270.

Identification & Billing

NDC Package Code
68047-702-35
Package Description
35 TABLET in 1 DOSE PACK
Product Code
68047-702
11-Digit Billing Format
68047070235
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
35 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Dexamethasone 1.5 Mg
Non-Proprietary Name
Dexamethasone 1.5 Mg
Substance Name
Dexamethasone
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
  • Oral - Administration to or by way of the mouth.
  • Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Regulatory & Marketing

Labeler Name
Larken Laboratories, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA201270
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-01-2017
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

J8540
Source: PDAC
DEXAMETHASONE, ORAL, 0.25 MG
HCPCS Dosage 0.25 MG
Units / Pkg

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (68047-702). Click a package code to view its specific billing and regulatory data.

68047-702-01
100 TABLET in 1 BOTTLE
68047-702-21
21 TABLET in 1 DOSE PACK
68047-702-51
51 TABLET in 1 DOSE PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68047-702-35 identifies a specific commercial package of 35 tablet in 1 dose pack of Dexamethasone 1.5 Mg, a human prescription drug labeled by Larken Laboratories, Inc.. This tablet is formulated for oral use and contains dexamethasone as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Larken Laboratories, Inc. on September 01, 2017. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

How is this Larken Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68047070235. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 35 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68047-702-35
11-Digit CMS (5-4-2)
68047-0702-35

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.